Pfizer tests new pill to fight advanced cancers
NCT ID NCT07318805
Summary
This early-stage study is testing a new oral medication called PF-08032562, both alone and in combination with other cancer drugs, for people with advanced or metastatic breast or colorectal cancer. The main goals are to find a safe dose and see how the body processes the drug. Researchers will enroll about 260 adults to take the pill in 28-day cycles and monitor for side effects and any impact on their cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
START Midwest, LLC
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START Mountain Region
NOT_YET_RECRUITINGWest Valley City, Utah, 84119, United States
-
START San Antonio
NOT_YET_RECRUITINGSan Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.